VGLS — VG Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $2.11m
- $6.11m
Annual cashflow statement for VG Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2010 December 31st | C2011 December 31st | C2012 December 31st | 2013 December 31st | 2014 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | ARS | 10-Q | 10-Q | 10-K |
| Standards: | — | — | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.24 | -5.42 | -6.85 | -7.42 | -6.19 |
| Depreciation | |||||
| Non-Cash Items | 5.55 | 3.11 | 3.86 | 3.4 | 4.44 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.608 | 1.29 | 2.03 | 2.98 | -0.161 |
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.01 | -1.02 | -0.96 | -1.04 | -1.91 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow Items | — | — | 0 | 0.125 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1 | 1.02 | 0.96 | 1.75 | 1.23 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.009 | -0.001 | 0 | 0.708 | -0.68 |